Cyteir Therapeutics, Inc. - stock earnings
CYT Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -3.5 million USD | ? USD |
| 2023Q2 | -8.4 million USD | ? USD |
| 2023Q1 | -11.6 million USD | ? USD |
| 2022Q4 | -7.4 million USD | ? USD |
| 2022Q3 | -10.3 million USD | ? USD |
| 2022Q2 | -12.0 million USD | ? USD |
| 2022Q1 | -14.1 million USD | ? USD |
| 2021Q4 | -11.8 million USD | ? USD |
| 2021Q3 | -11.7 million USD | ? USD |
| 2021Q2 | -11.3 million USD | ? USD |
| 2021Q1 | -7.3 million USD | ? USD |
| 2020Q4 | -5.4 million USD | ? USD |
| 2020Q3 | -5.0 million USD | ? USD |
| 2020Q2 | -4.5 million USD | ? USD |
| 2020Q1 | -5.9 million USD | ? USD |
CYT Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -33.2 million USD | ? USD |
| 2022 | -44.0 million USD | ? USD |
| 2021 | -41.6 million USD | ? USD |
| 2020 | -20.8 million USD | ? USD |
| 2019 | -15.0 million USD | 8000 USD |
CYT
Price: $3.02
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.93 USD
P/E Ratio: -3.38
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 92100
Market Capitalization: 108.7 million
Average Dividend Frequency: 4